Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease
Na Li, Shukai Zhan, Zhenyi Tian, et al.
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. 9, pp. 1525-1540
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms
Zuoting Yu, Dinggang Li, Hongxiang Sun
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114409-114409
Open Access | Times Cited: 57
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Lei Su, Yunhuan Gao, Rongcun Yang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 48
Advances in dietary polyphenols: Regulation of inflammatory bowel disease (IBD) via bile acid metabolism and the gut-brain axis
Kexin Jiang, Yun-Qing Bai, Ruyan Hou, et al.
Food Chemistry (2025) Vol. 472, pp. 142932-142932
Closed Access | Times Cited: 2
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment
Ruhan Zhang, Zhaobo Yan, Huan Zhong, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 15
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Yinping Pan, Haojie Zhang, Minghui Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
John C. Rowe, Jenessa A. Winston
Veterinary Sciences (2024) Vol. 11, Iss. 2, pp. 94-94
Open Access | Times Cited: 10
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response
Mengqi Zheng, Yunjiao Zhai, Yanbo Yu, et al.
Cell Metabolism (2024) Vol. 36, Iss. 9, pp. 2086-2103.e9
Closed Access | Times Cited: 9
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37
Dietary inflammatory potential mediated gut microbiota and metabolite alterations in Crohn's disease: A fire-new perspective
Zhenyi Tian, Xiaojun Zhuang, Shuyu Zhuo, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 6, pp. 1260-1271
Open Access | Times Cited: 33
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Aïcha Kriaa, Vincent Mariaule, Amin Jablaoui, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 901-901
Open Access | Times Cited: 31
hECA: The cell-centric assembly of a cell atlas
Sijie Chen, Yanting Luo, Haoxiang Gao, et al.
iScience (2022) Vol. 25, Iss. 5, pp. 104318-104318
Open Access | Times Cited: 29
The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 8, pp. 2181-2197
Open Access | Times Cited: 19
Dietary nobiletin regulated cefuroxime- and levofloxacin-associated “gut microbiota-metabolism” imbalance and intestinal barrier dysfunction in mice
Minmin Zhan, Xiaoshuang Yang, Chenxi Zhao, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1265-1278
Closed Access | Times Cited: 7
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review
Yichen Zong, Jie Meng, Tangyou Mao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Disentangling the nutrition-microbiota liaison in inflammatory bowel disease
Marilina Florio, Lucilla Crudele, Fabio Sallustio, et al.
Molecular Aspects of Medicine (2025) Vol. 102, pp. 101349-101349
Open Access
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Mengjiao Zhou, Danfeng Wang, Xiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease
Siyu Li, Xu Kan, Yi Cheng, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth
Yorinobu Maeda, Teruo Murakami
Antibiotics (2023) Vol. 12, Iss. 2, pp. 263-263
Open Access | Times Cited: 11
Gut Epithelial Barrier Function is Impacted by Hyperglycemia and Secondary Bile Acids in Vitro: Possible Rescuing Effects of Specific Pectins
Xin Tang, Xiaochen Chen, Michela Ferrari, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 11
Open Access | Times Cited: 4
The gut microbiota-bile acid axis in cholestatic liver disease
Dayan Sun, Chuanping Xie, Yong Zhao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
High-fat diet promotes gestational diabetes mellitus through modulating gut microbiota and bile acid metabolism
Lei Yao, Xuefei Zhou, X. S. Jiang, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
DOSY‐Assisted Multicomponent Characterization Enables Classification of Precious Chinese Materia Medica and Identification of Adulteration: A Case Study of Calculus Bovis
S.J. Li, Fang Cuifen, Sinan Wang, et al.
Phytochemical Analysis (2025)
Closed Access
Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases
Dan Pu, Zhe Zhang, Bai‐Sui Feng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Bile acid alterations associated with indolent course of inflammatory bowel disease
Caiguang Liu, Shukai Zhan, Na Li, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 58, Iss. 9, pp. 988-997
Closed Access | Times Cited: 9
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Tiangang Li, John Y.L. Chiang
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1221-1253
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top